TYK Medicines
Latest round
- Series D
Last raised
- Dec 2023
Total raised
- $182M
Investors
- 17
About TYK Medicines
Established in 2018 and based in Shanghai, China, TYK Medicines operates as a drug developer that engages in research and developing new tumour drugs. The small molecule drug screening platform has been established in Zhengzhou, and new drug formulation factories are being constructed in Changxing and Shanghai. The chairman of the board, Yusheng Wu, graduated from Iowa State University and worked as a senior chief researcher and project manager at Schering Lough New Drug Research and Development Center. In December 2022, the company was rated as a national high-tech enterprise.7 million in Pre-IPO and listed on the Hong Kong Exchange and Clearing Ltd. The company engages in the research and development of tumour drugs, as well as small molecule drug design and screening platforms for targeting therapeutics. The company opened TY-9591, TY-302, and TY-2136b and other product pipelines. The drug is suitable for breast cancer, prostate cancer, solid tumours, etc. TYK Medicines also has a deuterated drug research and development technology platform and a large molecule immunotherapy platform. The company generates revenue by providing antitumor small molecule drugs and develop drug platforms, treatment platforms, and R&D technology platforms.
Who invested in TYK Medicines
17 investors across 6 rounds
See all investors in TYK Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TYK Medicines
Who invested in TYK Medicines?
TYK Medicines has 17 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TYK Medicines raised?
TYK Medicines has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did TYK Medicines last raise money?
TYK Medicines's most recent round on record is a Series D, in Dec 2023.
What does TYK Medicines do?
Established in 2018 and based in Shanghai, China, TYK Medicines operates as a drug developer that engages in research and developing new tumour drugs.
Where is TYK Medicines headquartered?
TYK Medicines is headquartered in Shanghai, China.
Which VCs invest in companies like TYK Medicines?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at TYK Medicines's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like TYK Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.